Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ADEL-Y01 Alzheimer's Disease (Phase 1) ADEL, Inc., Oscotec Inc. Tau Immunotherapy (passive)
AL044 Alzheimer's Disease (Phase 1) Alector Inflammation Immunotherapy (passive)
ALIA-1758 Alzheimer's Disease (Phase 1) AbbVie, Aliada Therapeutics Amyloid-Related Immunotherapy (passive)
APNmAb005 RAA7 Alzheimer's Disease (Phase 1) Aprinoia Therapeutics Tau Immunotherapy (passive)
IBC-Ab002 Alzheimer's Disease (Phase 1) ImmunoBrain Checkpoint Amyloid-Related, Inflammation, Other Immunotherapy (passive)
Lu AF87908 hC10.2 Alzheimer's Disease (Phase 1) Lundbeck Tau Immunotherapy (passive)
MEDI1814 Alzheimer's Disease (Phase 1) AstraZeneca, Eli Lilly & Co. Amyloid-Related Immunotherapy (passive)
MK-2214 Alzheimer's Disease (Phase 1) Merck Tau Immunotherapy (passive)
PMN310 Alzheimer's Disease (Phase 1) ProMIS Neurosciences, Inc. Amyloid-Related Immunotherapy (passive)
PRX012 Alzheimer's Disease (Phase 1) Prothena Amyloid-Related Immunotherapy (passive)
TB006 Alzheimer's Disease (Phase 1) TrueBinding, Inc. Inflammation Immunotherapy (passive)
VY-TAU01 HC3LC2,
Voyager_9
Alzheimer's Disease (Phase 1) Voyager Therapeutics Tau Immunotherapy (passive)